Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

A new tool to assess Clinical Diversity In Meta-analyses (CDIM) of interventions

Research output: Contribution to journalJournal articleResearchpeer-review

  1. GRADE guidelines 32: GRADE offers guidance on choosing targets of GRADE certainty of evidence ratings

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Validation studies in epidemiologic research: Estimation of the positive predictive value

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Effect Modifiers and Statistical Tests for Interaction in Randomized Trials

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Evidence-Based Research Series-Paper 1: What Evidence-Based Research is and why is it important?

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Early specialised palliative care: interventions, symptoms, problems

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Was amorphous aluminium hydroxyphosphate sulfate adequately evaluated before authorisation in Europe?

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Handling oxygenation targets in ICU patients with COVID-19-Protocol and statistical analysis plan in the HOT-COVID trial

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Low-dose hydrocortisone in patients with COVID-19 and severe hypoxia: the COVID STEROID randomised, placebo-controlled trial

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

OBJECTIVE: To develop and validate Clinical Diversity In Meta-analyses (CDIM), a new tool for assessing clinical diversity between trials in meta-analyses of interventions.

STUDY DESIGN AND SETTING: The development of CDIM was based on consensus work informed by empirical literature and expertise. We drafted the CDIM tool, refined it, and validated CDIM for interrater scale reliability and agreement in three groups.

RESULTS: CDIM measures clinical diversity on a scale that includes four domains with 11 items overall: setting (time of conduct/country development status/units type); population (age; sex; patient inclusion criteria/baseline disease severity, comorbidities); interventions (intervention intensity/strength/duration of intervention; timing; control intervention; cointerventions);and outcome (definition of outcome; timing of outcome assessment). The CDIM is completed in two steps: first two authors independently assess clinical diversity in the four domains. Second, after agreeing upon scores of individual items a consensus score is achieved. Interrater scale reliability and agreement ranged from moderate to almost perfect depending on the type of raters.

CONCLUSION: CDIM is the first tool developed for assessing clinical diversity in meta-analyses of interventions. We found CDIM to be a reliable tool for assessing clinical diversity among trials in meta-analysis.

Original languageEnglish
JournalJournal of Clinical Epidemiology
Volume135
Pages (from-to)29-41
Number of pages13
ISSN0895-4356
DOIs
Publication statusPublished - Jul 2021

    Research areas

  • Diversity, Evidence, Heterogeneity, Meta-analysis, Quality, Systematic review, Tool

ID: 62238157